T HE PURPOSE of the work was to investigate the effects of acute increases in left ventricular pressure work on coronary blood flow, myocardial oxygen and carbohydrate utilization. We were able at the same time to evaluate the application of the nitrous oxide method to the measurement of changes in coronary blood flow resulting from druginduced changes in the pressure work.
A paired experimental design was used so that 2 consecutive periods of observation could be made on the same animal. The same type of study was then repeated at a later date with the same animal, the second control period being replaced by a period of drug infusion. We wished to test an experimental plan in which many observations were made on a few animals, each serving as its own control and each returning for several tests. The synthesis of Hypertensin II peptiden (Hypertensin)* has made it possible to compare the pressor potential of this drug with the results of experiments performed using angiotonin, renin and Hypertensin I. 1 --At present, the synthetic Hypertensin appears to correspond completely with the naturally occurring angiotensin.*- 4 This substance was tested since it might be the most potent pressor amine available and because it might eventually have more adA'antages and fewer disadvantages clinically than levarterenol. 5 " 7 To us, Hypertensin was an agent which might increase left ventricular pressure work independently of any increase in left ventricular stroke work or heart rate.
Methods The experimental design consisted of paired periods of observation for the purpose of comparing the changes in coronary blood flow and left ventricular work from the first to the second period, i.e., control-control. These differences were then compared with the changes observed in control-drug infusion experiments, using the same anesthesia in the same dog. The paired observations were made at intervals of approximately one month for any one dog. s~10 An identical procedure was used in all experiments, the time course being the same as shown in figure 1 . This figure illustrates a Hypertensin experiment, 1 of 7 tests made in this same animal on different days.
Young healthy dogs were studied under the combination anesthesia morphino-"Dial"-urethanepentobarbital-sodium (MDUP),* as recommended by Poltz.io *The technic for the administration of the anesthesia is as follows: A dose of 2.0 ing./Kg. of morphine is given subcutaneously. Forty-five minutes later, a 0.3 ml./Kg. injection of pentobarbitalsodiuni mixed with "Dial "-urethano (0.15 cc. of 65 mg./cc. pentobarbital-sodium and 0.15 cc. of '' Dial' '-nrethane is given intravenously. After 1 to .1-1/2 hours, during which time the animal is operated on and catheterized, and approximately 30 minutes before the first observation period, a second dose of morphine in the amount of 0.5 mg./Kg. is administered intramuscularly. A third dose of 0.5 nig./Kg. concentration given about 30 minutes before the second period of observation brings the total dosage of morphine to 3.0 mg./Kg. of body weight. During the paired control procedure, 0.9 per cent physiologic saline with 0.2 mg. per cent heparin was permitted to drip throughout the 2 periods. For the control part of the Hypertensin experiment a similar saline with heparin infusion was administered. This period was followed, after 20 to 30 minutes, by an lS-minute infusion of /ig./Ivg./min. of Hypertensin. The dosage of Hypertensin was selected after trial infusion of 1/3, 1 and 3 yug./Kg./min. had been tested and pressure responses established as being proportional to the dosage in this range. The drug was infused into a peripheral vein, using a constant rate infusion pump.
Arterial, mixed venous and coronary sinus blood samples necessary for measurements of coronary blood flow and cardiac output were drawn in the final 12 minutes when a relatively steady state had been established. An interval of 25 to 30 minutes between duplicate runs was allowed for saturation with nitrous oxide gas. We assumed that the coronary flow remained con- stant during its period of measurement. This assumption was probably not valid during the drug infusion periods. Also assumed to be unchanged during the time of the flow measurement were the cardiac arteriovenous metabolite differences. Seven-hole, 3-way stopcock manifolds, on which lightly oiled, heparinized, 10-ml. syringes were mounted, were used to draw discontinuous blood samples for the nitrous oxide coronary blood flow determinations. Femoral artery and coronarj sinus blood samples were taken at a rate of 1 nil. every 10 seconds. Six pairs of these arteriovenous samples were drawn for the coronary blood flow determination. The first pair was drawn during the last minute of inhalation of the 15 per cent nitrous oxide gas mixture. Compensation was made for the dead space in the sampling system. The other samples were collected during the first, second, third, fourth, and tenth minutes of nitrous oxide desaturation. The analysis of these samples served as a basis for plotting the nitrous oxide desaturation curves. Three 12-cc. samples were drawn over the fifth and sixth minutes of desaturation at the same rate of 1 cc. every 10 seconds from the femoral artery, coronary sinus and pulmonary artery.
These 12-cc. blood samples were used for the analysis of oxygen and carbon dioxide content, Arterial O 3
•Symbols: C: Mean observed value during initial control period of control-to-control studies. CH: Mean observed value during initial control period of control-to-Hypertensin studies. C-C: Mean change from initial control period to second control period. C-H: Mean change from initial control period to second Hypertensin period. tp<0.01. the pulmonary artery samples being necessary for the determination of the cardiac output. The same femoral artery and coronary sinus samples were also used for the determination of the hydrogen ion concentration with a Cambridge pH meter and for the determination of the hemoglobin concentrations with an Evelyn colorimeter. From these data, the oxygen tension was calculated, using the charts of Dill. 11 Hematocrits were read after spinning the samples at 2,000 r.p.m. for 30 minutes. The oxygen tension of the blood was calculated from the derived coronary sinus venous oxygen, the arterial blood saturation and pH values. Utilizing the pH and carbon dioxide values, nomograms were employed to obtain the tension of carbon dioxide. 12 One more pair of samples from the femoral artery and coronary sinus, drawn in unoiled heparinized syringes during the seventh minute of desaturation, was used for the determination of Circulation Research, Volume VIII, November 1900 glucose, lactate and pyruvate blood levels. Lactate levels were assessed by determining the lactic acid with a modified method based on that of Barker and Summerson, pyruvie acid according to the method of Friedmann and Haugen for blood pyruvate and blood glucose with the procedure as outlined by Hagedorn and Jensen with a modification by Somogyi. 9 The expired air was collected from the second to the seventh minute of the desaturation period. The gas samples were analyzed for oxygen and carbon dioxide, using the method of Scholander.
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The nitrous oxide blood determinations for the Hypertensin results were done by the infrared absorption analysis method.
14 The formula used was the general one applying the Fick principle to left ventricular blood flow and involved dividing the final venous nitrous oxide value by the sum of the A-V differences.
After the observations were made, the catheters 
Figure 3 Tliis bar graph shows the per cent change from the first to the second period of observation wider morphine-"I)iaV'-tirethane-pent'obarbital-soitium anesthesia. The data on cardiac output, mean arterial pressure, left ventricular work, coronary floiv and cardiac oxygen metabolism during Sripertensiii are shown in the column on the right. The control-control studies are represented under "'Anesthesia alone." The broken lines show the per cent coefficients of variation (the ratio of the standard deviations of the individual differences to the initial values of the parameters). The upper portion of the figure includes cardiac output (CO), mean arterial pressure (MAP) and left ventricular work (LYW), and the lower portion
wove removed and the skin sutured. Tlie iuiini;il wns given procaine penicillin and protamine sulfate and was observed in the laboratory for 6 to J2 hours before being 1 returned to the veterinarian. After 24 to 4S hours observation in the veterinarian's hospital, the dog-was taken to a farm where it lived under natural conditions until the time for the next experiment 3 to 4 weeks later. When n dog's external jugular veins become thrombosed after 3 to 7 experiments so that further catheterizations were impossible, the dog was sacrificed and the heart removed, dissected and weighed, as described by Folt/.. 10 
Calculations
The various eardiodynamic and metabolic functions were calculated by applying the basic-data, as has been previously reported : s~10 coronary blood flow in inL/100 Gin. left ventricle/rnin. by the method of Kety and Selnuidt;* cardiac; output in L./min. by the direct Fick method; cardiac work (Kg.M./ min.) from mean arterial blood pressure and cardiac output; coronary resistance, expressed as mean arterial blood pressure -rcoronary flow.
The left ventricular uptake for each of the metabolites-glucose, lactate, pyruvate and oxygen-was calculated by multiplying its coronary arteriovenous difference by the coronary blood flow, thereby obtaining a value •for uptake in ni<r./10() Gm. left ventricle/min. or, for oxygen, cc/100 Gin. of left ventricle/ min. The per cent myocardial extraction was also determined for oxygen, lactate, pyruvate and glucose. Left ventricular mechanical efficiency was calculated as previously described. 8 -Al 1 of the data acquired during the paired coronary flow determinations were considered on the basis of the mean change from the first to the second observation. The mean values of the changes from the first control to the second control were compared with the mean values of the changes from the control to the *l)ctails of tin* method used in this laboratory liave been mimeographed and may bo obtained by writing to Ivan E. Porte. (table 1) . Statistically, these mean differences were " t " tested as to the difference of the mean differences with a less than 1 per cent chance of coincidence being called significant. .1240
shoics coronarji blood flow (CBF), cardiac urteriovenoits oxygen difference (A A-VO t ) and oxygen consumption (O 2 cons.). See text.
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The dotted line shows the per cent coefficient of variation (the standard deviation of the individual differences divided by the initial value of the parameter X 100). The pressure elevation and the work increase induced by Hypertensin are greater than the per cent coefficient of variation. In the bottom of the same figure are shown the components of cardiac oxygen consumption. The apparent greater coronary blood flow and cardiac oxygen utilization rate with Hypertensin were associated with the increased pressure work.
The percentage coefficient of variation of coronary blood flow was large in this small series of dogs. It was not possible to measure a significant increase in coronary flow during the acutely induced increases in pressure work.
These experiments showing the great variance in coronary blood flow ( fig. 3 ) have convinced us of the difficulties involved in interpreting the results of paired observations in clinical experiments (using the nitrous oxide method) designed to compare the mean values of coronary blood flow and cardiac oxygen utilization during a drug action with the mean values observed initially.
The experiments do show that in healthy young dogs with adequate coronary arteries, the oxygen tension of the myocardial cells, as reflected in left ventricular venous blood draining into the coronary sinus, was maintained in a relatively low range, 11.4 to 30.6 mm. Hg. Coronary sinus ox3'gen tension was unchanged during the drug infusion. This lack of change implies that under these experimental conditions, Hypertensin has the ability either to open cardiac arteriovenous shunts or to increase coronary blood flow to meet the demand for increased myocardial oxygen. If the latter is true, then the findings support the thesis that coronary resistance is regulated to insure adequate blood transport for the requirements of cardiac oxygen metabolism.
Evidence of hemoconcentration was observed during the action of Hypertensin. Theresulting hyperglycemia might have been a consequence of stimulation of the adrenal medulla. Under the apparent adverse conditions of increased vasoconstriction, peripheral hypoxia, greater glycogenolysis and increased left ventricular work, the heart muscle cells were able to utilize lactate ions at a 4-fold greater rate (2.5 to 10.7 mg./lOO Gm./min.). Other workers have suggested that the utilization of lactate is related to the amount available in the arterial blood. 16 Summary Pharmacodynamically induced changes in left ventricular work, using an intravenous infusion of Hypertensin, were studied in intact anesthetized dogs. Coronary and systemic hemodynamics and cardiac metabolism under a combined morphine-'' Dial' '-urethanepentobarbital-sodium (MDUP) anesthesia were measured during the action of the drug. The significant hemodynamic changes induced were increased mean arterial pressure and increased left ventricular Avork. A greater cardiac lactate utilization during the Hypertensin infusion was the only change in cardiac metabolism. The oxygen tension in left ventricular venous blood was not reduced during the action of the drug.
Summario in Interlingua
Pharmacodynamicamente inducite alterationes in le labor sinistro-ventricular (eon le uso do infusiones intravenose de Hypertensina) esseva studiate in intacte anesthesiate canes. Le hemodynamica coronari o systemic e le metabolismo cardiac sub un anesthesia combinate per MDUP ( = morphina, Dial, urethano, pentobarbital a natrium) esseva mesurate durante le action del droga. Le significcitive alterationes hemodynamic inducite esseva im augmento del tension arterial medie e un augmento del labor sinistro-ventricular. Un plus grande utilisation cardiac de lactato durante le infusion de Hypertensina esseva le sol alteration del metabolismo cardiac. Le tension de oxygeno in sanguine venose sinistro-ventricular non esseva reducite durante le action del droga.
